Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
85.71M | 85.58M | 83.76M | 106.47M | 67.89M | 1.21B | Gross Profit |
18.74M | 17.72M | 16.00M | 7.80M | 12.28M | 26.13M | EBIT |
-13.35M | -13.23M | -15.34M | -27.11M | -29.93M | -58.03M | EBITDA |
-13.26M | -7.09M | -20.44M | -14.37M | -18.41M | -76.74M | Net Income Common Stockholders |
-11.35M | -11.87M | -26.02M | -29.13M | -66.98M | -87.25M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
62.54M | 37.60M | 49.61M | 55.01M | 30.33M | 18.54M | Total Assets |
792.82M | 125.11M | 144.60M | 175.61M | 230.16M | 257.62M | Total Debt |
172.01M | 237.00K | 985.00K | 9.18M | 90.17M | 81.86M | Net Debt |
109.47M | -37.37M | -48.62M | -45.83M | 59.83M | 63.32M | Total Liabilities |
563.61M | 31.30M | 38.69M | 42.95M | 135.04M | 124.53M | Stockholders Equity |
229.21M | 93.81M | 105.91M | 132.66M | 95.12M | 133.09M |
Cash Flow | Free Cash Flow | ||||
4.47M | -11.25M | 6.28M | -27.24M | 39.65M | -24.05M | Operating Cash Flow |
5.26M | -8.00M | 6.84M | -25.97M | 41.36M | -22.32M | Investing Cash Flow |
-750.00K | -3.21M | -10.93M | 52.00M | -16.87M | 101.11M | Financing Cash Flow |
-1.22M | -780.00K | -1.06M | -1.62M | -26.22M | -112.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $25.51B | 10.05 | 11.12% | 7.01% | -6.53% | -18.43% | |
67 Neutral | $153.32B | 11.93 | 11.39% | 3.01% | -2.65% | -14.96% | |
64 Neutral | $4.39B | 11.81 | 5.20% | 249.38% | 3.96% | -12.36% | |
58 Neutral | $2.84B | ― | -6.89% | 18.23% | -7.62% | -328.97% | |
57 Neutral | HK$559.61M | 15.33 | 1.56% | ― | -9.62% | -58.90% | |
54 Neutral | HK$208.11M | ― | -11.94% | ― | 15.37% | -6.06% | |
44 Neutral | HK$389.95M | 33.97 | ― | -23.08% | -85.52% |
Daisho Microline Holdings Limited, through its indirect wholly-owned subsidiary, has entered into a Capital Injection Agreement to subscribe for registered capital in a target company for RMB28,500,000. This transaction will result in Daisho Microline holding approximately 15.12% of the enlarged registered capital of the target company, which will be accounted as an associated company, but its financial results will not be consolidated into Daisho’s financial statements. The transaction is classified as a discloseable transaction under the Hong Kong Listing Rules, subject to reporting and announcement requirements, but exempt from shareholders’ approval.